课题基金 / 基金详情

I-Corps: A Novel Approach to Parent-Child Communication

I-Corps: A Novel Approach to Parent-Child Communication
I-Corps:亲子沟通的新方法
批准号:
2224291
负责人:
Laura Widman
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-15 至 2024-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project is the development of digital health technologies (e.g., wearable devices and personalized medicine) that can be used to address sexual health problems. There are nearly 10 million new cases of sexually transmitted disease (STD) each year in the U.S. Treatments for STDs are estimated to cost $16 billion annually. The proposed technologies seek to improve education and communication and, in doing so, may provide positive health outcomes for both individuals and their families.This I-Corps project is based on the development improved parent-child communications and the reduction of healthcare costs associated sexually-transmitted diseases among adolescents. This innovation stems from the combination of several elements including building motivation for communication by shifting parental mindsets, providing skill-building exercises, and providing a new platform for parent-child communication. This combination of features is not currently available in any other book, website, or product on the market.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: